Reddy LM - Search Results

1

14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.

Gauthier KM, Falck JR, Reddy LM, Campbell WB. Gauthier KM, et al. Among authors: reddy lm. Pharmacol Res. 2004 Jun;49(6):515-24. doi: 10.1016/j.phrs.2003.09.014. Pharmacol Res. 2004. PMID: 15026029

2

Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation.

Yang W, Gauthier KM, Reddy LM, Sangras B, Sharma KK, Nithipatikom K, Falck JR, Campbell WB. Yang W, et al. Among authors: reddy lm. Hypertension. 2005 Apr;45(4):681-6. doi: 10.1161/01.HYP.0000153790.12735.f9. Epub 2005 Feb 7. Hypertension. 2005. PMID: 15699458

3

11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression.

Falck JR, Reddy LM, Reddy YK, Bondlela M, Krishna UM, Ji Y, Sun J, Liao JK. Falck JR, et al. Among authors: reddy lm, reddy yk. Bioorg Med Chem Lett. 2003 Nov 17;13(22):4011-4. doi: 10.1016/j.bmcl.2003.08.060. Bioorg Med Chem Lett. 2003. PMID: 14592496

4

Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.

Yu M, Cambj-Sapunar L, Kehl F, Maier KG, Takeuchi K, Miyata N, Ishimoto T, Reddy LM, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Yu M, et al. Among authors: reddy lm. Eur J Pharmacol. 2004 Feb 23;486(3):297-306. doi: 10.1016/j.ejphar.2004.01.009. Eur J Pharmacol. 2004. PMID: 14985052

5

Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation.

Dimitropoulou C, West L, Field MB, White RE, Reddy LM, Falck JR, Imig JD. Dimitropoulou C, et al. Among authors: reddy lm. Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):50-61. doi: 10.1016/j.prostaglandins.2006.09.008. Epub 2006 Nov 7. Prostaglandins Other Lipid Mediat. 2007. PMID: 17259072

6

Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells.

Jiang H, McGiff JC, Quilley J, Sacerdoti D, Reddy LM, Falck JR, Zhang F, Lerea KM, Wong PY. Jiang H, et al. Among authors: reddy lm. J Biol Chem. 2004 Aug 27;279(35):36412-8. doi: 10.1074/jbc.M403962200. Epub 2004 Jun 22. J Biol Chem. 2004. PMID: 15213230 Free article.

7

Red blood cells: reservoirs of cis- and trans-epoxyeicosatrienoic acids.

Jiang H, Quilley J, Reddy LM, Falck JR, Wong PY, McGiff JC. Jiang H, et al. Among authors: reddy lm. Prostaglandins Other Lipid Mediat. 2005 Jan;75(1-4):65-78. doi: 10.1016/j.prostaglandins.2004.10.003. Prostaglandins Other Lipid Mediat. 2005. PMID: 15789616

8

Epoxygenase eicosanoids: synthesis of tetrahydrofuran-diol metabolites and their vasoactivity.

Falck JR, Reddy LM, Byun K, Campbell WB, Yi XY. Falck JR, et al. Among authors: reddy lm. Bioorg Med Chem Lett. 2007 May 1;17(9):2634-8. doi: 10.1016/j.bmcl.2007.01.096. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17293113 Free PMC article.

9

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.

Ng VY, Huang Y, Reddy LM, Falck JR, Lin ET, Kroetz DL. Ng VY, et al. Among authors: reddy lm. Drug Metab Dispos. 2007 Jul;35(7):1126-34. doi: 10.1124/dmd.106.013839. Epub 2007 Apr 12. Drug Metab Dispos. 2007. PMID: 17431031

10

Practical, asymmetric synthesis of 16-hydroxyeicosa-5(Z),8(Z), 11(Z),14(Z)-tetraenoic acid (16-HETE), an endogenous inhibitor of neutrophil activity.

Reddy YK, Reddy LM, Capdevila JH, Falck JR. Reddy YK, et al. Among authors: reddy lm. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3719-20. doi: 10.1016/j.bmcl.2003.08.005. Bioorg Med Chem Lett. 2003. PMID: 14552765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page